16 September 2022 · A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland
8 January 2020 · A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012
24 January 2022 · The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)
15 July 2024 · Whether a healthcare professional (HCP) can prepare and/or administer contrast supplied by another HCP under a PGD will depend on a range of factors.
28 April 2022 · Hormone Replacement Therapy availability varies currently. Check for available products and keep up-to-date. Supply content is maintained regularly by DHSC.
22 February 2022 · Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input
2 April 2024 · Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.